查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1800305

采血管市场：未来预测（2025-2030）

Blood Collection Tubes Market - Forecasts fom 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 140 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计采血管市场规模将从 2025 年的 35.03 亿美元成长至 2030 年的 46.33 亿美元，复合年增长率为 5.75%。

由于慢性病盛行率上升、人口老化以及外科手术增多，全球采血管市场可望显着成长。血液检测和储存需求日益增长，尤其是对于糖尿病和癌症等需要频繁诊断的疾病，推动了该市场的蓬勃发展。采血管设计技术的进步，包括效率的提高和易用性的提升，进一步推动了需求的成长。儘管面临製造成本高昂和法规复杂等挑战，但强大的医疗基础设施仍为该市场提供了支撑，其中美国凭藉其先进的医疗生态系统和高检测量，正在成为市场主导。

市场驱动因素

糖尿病和癌症等慢性疾病的日益流行，是频繁进行血液检测以进行诊断和监测的主要驱动因素。世界卫生组织 (WHO) 报告称，全球共有 1,020 万例结核病病例，其中包括 120 万名儿童，这凸显了对可靠采血系统的需求。外科手术数量的增加也推动了市场成长，使得采血管对于术前和术后检测至关重要。例如，葡萄牙、丹麦、挪威和爱尔兰等欧洲国家的外科手术量很高，凸显了对高效采血解决方案的需求。此外，血清分离技术的进步，例如 BD 于 2023 年 1 月推出的含 K2EDTA 的 Vacutainer® 血清管，提高了可用性并支持外科手术，进一步推动了市场扩张。 WHO 2023 年 6 月的资料显示，共采集了 1.185 亿个采血管。全球捐血的增加进一步扩大了对专用采血管的需求，以确保血液的安全储存和检测。

目录

第一章 引言

  • 市场概览
  • 市场定义
  • 分析范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表

第二章 分析方法

  • 分析设计
  • 分析数据
  • 检验

第三章执行摘要

  • 主要分析结果

第四章 市场动态

  • 市场驱动因素
  • 市场限制
  • 波特五力分析
  • 产业价值链分析

第五章采血管市场依产品类型分析

  • 介绍
  • EDTA管
  • 肝素管
  • 肝素血浆分离管
  • 血清分离管
  • 其他的

第六章 采血管市场依材质分析

  • 介绍
  • 塑胶
    • 聚对苯二甲酸乙二酯
    • 聚丙烯
    • 聚苯乙烯
    • 其他的
  • 玻璃

第七章 采血管市场分析（依最终使用者）

  • 介绍
  • 诊断中心
  • 医院和诊所
  • 研发中心

第八章 采血管市场区域分析

  • 介绍
  • 北美洲
    • 依产品类型
    • 依材料类型
    • 按最终用户
    • 按国家
      • 美国
      • 加拿大
      • 墨西哥
  • 南美洲
    • 依产品类型
    • 依材料类型
    • 按最终用户
    • 按国家
      • 巴西
      • 阿根廷
      • 其他的
  • 欧洲
    • 依产品类型
    • 依材料类型
    • 按最终用户
    • 按国家
      • 英国
      • 德国
      • 法国
      • 西班牙
      • 其他的
  • 中东和非洲
    • 依产品类型
    • 依材料类型
    • 按最终用户
    • 按国家
      • 沙乌地阿拉伯
      • 阿拉伯聯合大公国
      • 以色列
      • 其他的
  • 亚太地区
    • 依产品类型
    • 依材料类型
    • 按最终用户
    • 按国家
      • 日本
      • 中国
      • 印度
      • 韩国
      • 印尼
      • 台湾
      • 其他的

第九章竞争格局及分析

  • 主要企业和策略分析
  • 新兴企业和市场盈利
  • 企业合併、协议、商业合作
  • 供应商竞争力矩阵

第十章：公司简介

  • BD
  • Cardinal Health
  • CHENGDU RICH SCIENCE INDUSTRY CO., LTD.
  • FL MEDICAL Srl
  • Fresenius Kabi AG
  • Greiner Bio One International GmbH
  • Thermo Fisher Scientific Inc.
  • Kawasumi Laboratories America
  • McKesson Medical-Surgical Inc.
  • QIAGEN
  • SARSTEDT AG & Co. KG
  • AdvaCare Pharma
简介目录
Product Code: KSI061613462

The Blood Collection Tubes Market is expected to grow from USD 3.503 billion in 2025 to USD 4.633 billion in 2030, at a CAGR of 5.75%.

The global blood collection tubes market is poised for significant growth, driven by the rising prevalence of chronic diseases, an aging population, and increasing surgical procedures. The market is fueled by the growing need for blood testing and storage, particularly for conditions like diabetes and cancer, which require frequent diagnostics. Technological advancements in tube design, such as improved efficiency and user-friendliness, further propel demand. Despite challenges like high production costs and regulatory complexities, the market is supported by robust healthcare infrastructure, with the United States emerging as a dominant market due to its advanced medical ecosystem and high testing volumes.

Market Drivers

The increasing incidence of chronic diseases, such as diabetes and cancer, is a primary driver, necessitating frequent blood tests for diagnosis and monitoring. The World Health Organization reported 10.2 million tuberculosis cases globally, including 1.2 million children, highlighting the demand for reliable blood collection systems. The growing number of surgical procedures also boosts market growth, as blood collection tubes are essential for preoperative and postoperative testing. For instance, high surgical volumes in European countries like Portugal, Denmark, Norway, and Ireland underscore the need for efficient blood collection solutions. Additionally, technological advancements, such as BD's Vacutainer(R) Serum Tube with K2EDTA launched in January 2023 for serum separation, enhance usability and support surgical applications, driving market expansion. The global rise in blood donations, with 118.5 million units collected as per WHO's June 2023 data, further amplifies demand for specialized tubes to ensure safe storage and testing.

Market Segmentation

The market is segmented by application, tube type, and geography. Applications include diagnostics, surgical procedures, and blood donation, with diagnostics leading due to chronic disease prevalence. Tube types encompass serum, plasma, and EDTA tubes, tailored to specific testing needs. Geographically, the market spans North America, South America, Europe, the Middle East and Africa, and Asia Pacific. The United States dominates North America, driven by its USD 3.8 trillion healthcare industry in 2022 and high surgical and diagnostic activity. The integration of microfluidics in point-of-care (POC) diagnostics, enabling portable and affordable testing, further supports market growth in the region.

Industry Analysis

Porter's Five Forces model evaluates competitive dynamics, analyzing supplier power, buyer influence, and market rivalry. An industry value chain analysis identifies key players in tube manufacturing, distribution, and healthcare integration, emphasizing their roles in ensuring quality and efficiency. The regulatory framework, including standards for medical device safety and quality, is critical for maintaining trust and compliance, particularly in high-income countries with stringent healthcare regulations.

Competitive Landscape

Key players, such as BD, focus on innovation, developing advanced tubes like the Vacutainer(R) series to meet surgical and diagnostic needs. The vendor matrix categorizes companies as leaders, followers, challengers, or niche players based on their strategies, with an emphasis on user-friendly and efficient solutions. Investments in R&D and partnerships with healthcare providers strengthen market positions.

Challenges

High production costs for advanced blood collection tubes and stringent regulatory requirements pose barriers. Ensuring consistent quality across diverse applications and addressing supply chain constraints in developing regions are additional challenges requiring strategic solutions.

The blood collection tubes market is set for robust growth, driven by chronic disease prevalence, surgical demand, and technological advancements. The U.S. leads due to its advanced healthcare infrastructure and high testing volumes, while Asia Pacific shows potential with rising healthcare needs. Continued innovation and regulatory compliance will be critical for overcoming cost and quality challenges, ensuring the market meets global diagnostic and surgical demands.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2020 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation:

By Product Type

  • EDTA Tubes
  • Heparin Tube
  • Heparin Plasma Separating Tube
  • Serum Separating Tube
  • Others

By Material Type

  • Plastic
  • Polyethylene Terephthalate
  • Polypropylene
  • Polystyrene
  • Others
  • Glass

By End-User

  • Diagnostics Centers
  • Hospitals and Clinics
  • R&D Centers

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Data
  • 2.3. Validation

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. BLOOD COLLECTION TUBES MARKET ANALYSIS, BY PRODUCT TYPE

  • 5.1. Introduction
  • 5.2. EDTA Tubes
  • 5.3. Heparin Tube
  • 5.4. Heparin Plasma Separating Tube
  • 5.5. Serum Separating Tube
  • 5.6. Others

6. BLOOD COLLECTION TUBES MARKET ANALYSIS, BY MATERIAL TYPE

  • 6.1. Introduction
  • 6.2. Plastic
    • 6.2.1. Polyethylene Terephthalate
    • 6.2.2. Polypropylene
    • 6.2.3. Polystyrene
    • 6.2.4. Others
  • 6.3. Glass

7. BLOOD COLLECTION TUBES MARKET ANALYSIS, BY END-USER

  • 7.1. Introduction
  • 7.2. Diagnostics Centers
  • 7.3. Hospitals and Clinics
  • 7.4. R&D Centers

8. BLOOD COLLECTION TUBES MARKET ANALYSIS, BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Product Type
    • 8.2.2. By Material Type
    • 8.2.3. By End-Users
    • 8.2.4. By Country
      • 8.2.4.1. United States
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Product Type
    • 8.3.2. By Material Type
    • 8.3.3. By End-Users
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Product Type
    • 8.4.2. By Material Type
    • 8.4.3. By End-Users
    • 8.4.4. By Country
      • 8.4.4.1. UK
      • 8.4.4.2. Germany
      • 8.4.4.3. France
      • 8.4.4.4. Spain
      • 8.4.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Product Type
    • 8.5.2. By Material Type
    • 8.5.3. By End-Users
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. United Arab Emirates
      • 8.5.4.3. Israel
      • 8.5.4.4. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Product Type
    • 8.6.2. By Material Type
    • 8.6.3. By End-Users
    • 8.6.4. By Country
      • 8.6.4.1. Japan
      • 8.6.4.2. China
      • 8.6.4.3. India
      • 8.6.4.4. South Korea
      • 8.6.4.5. Indonesia
      • 8.6.4.6. Taiwan
      • 8.6.4.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Emerging Players and Market Lucrativeness
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Vendor Competitiveness Matrix

10. COMPANY PROFILES

  • 10.1. BD
  • 10.2. Cardinal Health
  • 10.3. CHENGDU RICH SCIENCE INDUSTRY CO., LTD.
  • 10.4. FL MEDICAL S.r.l.
  • 10.5. Fresenius Kabi AG
  • 10.6. Greiner Bio One International GmbH
  • 10.7. Thermo Fisher Scientific Inc.
  • 10.8. Kawasumi Laboratories America
  • 10.9. McKesson Medical-Surgical Inc.
  • 10.10. QIAGEN
  • 10.11. SARSTEDT AG & Co. KG
  • 10.12. AdvaCare Pharma